Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) SVP Douglas Beck sold 2,650 shares of Adtalem Global Education stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.40, for a total transaction of $358,810.00. Following the completion of the sale, the senior vice president directly owned 35,509 shares in the company, valued at $4,807,918.60. This represents a 6.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Price Performance
NYSE CVSA traded up $0.32 on Thursday, hitting $131.17. The company had a trading volume of 316,206 shares, compared to its average volume of 371,981. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The company’s fifty day moving average price is $124.04. The stock has a market capitalization of $4.46 billion, a P/E ratio of 20.43, a PEG ratio of 1.02 and a beta of 0.62. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million for the quarter. During the same period in the previous year, the business earned $1.92 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, sell-side analysts anticipate that Adtalem Global Education Inc. will post 8.04 EPS for the current year.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on Adtalem Global Education
Adtalem Global Education Company Profile
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Read More
- Five stocks we like better than Adtalem Global Education
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
